companydata.dkABL BIOTEC A/S: Financial statements 2018
CVR: 50811018
ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -109,236 and a net result of DKK -1,956,129 compared with DKK 1,139,039 the year before. Equity amounted to DKK 21,521,493. The solvency ratio was 99.1%. The company had 1 employee in the financial year.
- Gross Profit
- -109,236 kr.
- Profit/Loss
- -1,956,129 kr.
- Equity
- 21,521,493 kr.
- Total Assets
- 21,726,194 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -109 t. | -2 mio. | 21.5 mio. | 1 |
| 2017 | - | -125 t. | 1.1 mio. | 24.6 mio. | 1 |
| 2016 | - | -118 t. | 796 t. | 24.5 mio. | 1 |
| 2015 | - | -122 t. | 2.2 mio. | 24.8 mio. | - |
| 2014 | - | -100 t. | 3.8 mio. | 23.7 mio. | - |
Keep an eye on ABL BIOTEC A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
ABL BIOTEC A/S has published its annual report for 2017. Gross profit came to DKK -125,116, and the net result was DKK 1,139,039.
About ABL BIOTEC A/S
ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Asger Bach-Larsen. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 0 employees. In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity amounted to DKK 27,884,586.